PRESS RELEASE published on 12/17/2025 at 09:30, 7 days 9 hours ago Topadur Appoints Matthias Schäfer as Chief Executive Officer to Lead Next Phase of Company Growth Topadur Pharma AG appoints Matthias Schäfer as Chief Executive Officer to lead company growth into next phase of clinical development and expansion. Dr. Reto Naef transitions to Senior Scientific Advisor Clinical Development Chief Executive Officer Topadur Pharma AG Matthias Schäfer Scientific Advisor
PRESS RELEASE published on 12/17/2025 at 09:30, 7 days 9 hours ago Designated Person Notification Aperam announces Designated Person Notification regarding share transactions as per Market Abuse Regulations. Aperam is a global stainless steel player committed to the circular economy Share Transactions Market Abuse Regulations Aperam Circular Economy Designated Person Notification
PRESS RELEASE published on 12/17/2025 at 09:21, 7 days 10 hours ago Heidelberg Pharma: Letter from the CEO Heidelberg Pharma CEO addresses delays in milestone payment, emphasizing continued development of TLX250-CDx and promising phase I study results for pamlectabart tismanitin (HDP-101). Financial challenges are being addressed proactively CEO Heidelberg Pharma Milestone Payment TLX250-CDx Pamlectabart Tismanitin
PRESS RELEASE published on 12/17/2025 at 09:05, 7 days 10 hours ago Norgine enhances hepatology and specialty portfolio through exclusive in-licensing agreement with Vir Biotechnology Norgine enhances hepatology and specialty portfolio by in-licensing Vir Biotechnology's chronic hepatitis delta treatment for Europe, Australia, and New Zealand Exclusive Licensing Agreement Specialty Pharmaceuticals Norgine Vir Biotechnology Chronic Hepatitis Delta Treatment
PRESS RELEASE published on 12/17/2025 at 09:05, 7 days 10 hours ago Over 40% of Adults Struggle to Swallow Pills - BioNxt Targets a Global Adherence Problem with Rapid-Dissolving Thin-Film “Melt-in-Your-Mouth” Therapies BioNxt Solutions Inc. announces breakthrough in drug delivery for dysphagia, securing first national-level patent for thin-film platform, targeting autoimmune markets with bioequivalent cladribine treatment BioNxt Solutions Inc. Drug Delivery Dysphagia Thin-film Platform Autoimmune Markets
PRESS RELEASE published on 12/17/2025 at 09:00, 7 days 10 hours ago Financial Conduct Authority: Financial Conduct Authority admits multiple securities to the Official List on 17-Dec-2025, including shares, ETFs, and debt-like securities from various issuers Securities Financial Conduct Authority Official List Issuers Debt-like Securities
PRESS RELEASE published on 12/17/2025 at 09:00, 7 days 10 hours ago Removal- Diversity Funding No. 1 Limited Financial Conduct Authority removes Diversity Funding No. 1 Limited securities from the Official List on 17/12/2025, 08:00 GMT. Debt-like securities delisted Securities Financial Conduct Authority Official List Debt-like Securities Diversity Funding No. 1 Limited
PRESS RELEASE published on 12/17/2025 at 08:30, 7 days 10 hours ago Neo Energy Metals plc - Restoration The Financial Conduct Authority restores Neo Energy Metals plc to the Official List, effective from 17/12/2025, 07:30 GMT/BST Financial Conduct Authority Equity Shares Restoration Official List Neo Energy Metals Plc
PRESS RELEASE published on 12/17/2025 at 08:30, 7 days 10 hours ago GLOBAL ESG MONITOR 2025: MATERIALITY ANALYSIS WIDELY ADOPTED – INTEGRATION INTO RISIK MANAGEMENT SHOWS GAPS Global ESG Monitor 2025 reveals gaps in integrating materiality analysis into risk management among DAX companies, showcasing discrepancies with stakeholder expectations Risk Management ESG Materiality Analysis DAX Companies Stakeholder Expectations
PRESS RELEASE published on 12/17/2025 at 08:30, 7 days 10 hours ago Aquis Stock Exchange: Suspension from trading Valereum Plc's Ordinary Shares (Symbol: VLRM, ISIN: GI000A2P2W41) suspended from trading on Aquis Stock Exchange's Growth Market as of 17th Dec 2025 08:00 GMT/BST Ordinary Shares Trading Aquis Stock Exchange Suspension Valereum Plc
Published on 12/24/2025 at 15:25, 4 hours ago CORRECTION: Nextech3D.ai Provides Shareholder Update on Krafty Labs Acquisition and Announces $321,917 CEO Investment
Published on 12/24/2025 at 14:00, 5 hours 25 minutes ago Goldgroup Secures Ownership of the San Francisco Gold Mine Acquiring 100% of Molimentales del Noroeste, S.A. De C.V.
Published on 12/24/2025 at 14:00, 5 hours 25 minutes ago Alta Copper Announces Filing and Mailing of Meeting Materials for the Special Meeting of Shareholders and Optionholders to be Held on January 26, 2026
Published on 12/24/2025 at 05:00, 14 hours 25 minutes ago Alphinat Inc. and the Hague Conference on Private International Law (HCCH) Today Announced the Launch of the New e-Country Profile Platform
Published on 12/24/2025 at 16:30, 2 hours 54 minutes ago ABB Ltd: ABB share buybacks - December 18, 2025 - December 23, 2025
Published on 12/24/2025 at 15:07, 4 hours 17 minutes ago Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc.
Published on 12/24/2025 at 15:06, 4 hours 18 minutes ago Form 8.3 - The Vanguard Group, Inc.: JTC plc
Published on 12/24/2025 at 15:06, 4 hours 19 minutes ago Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc
Published on 12/24/2025 at 15:05, 4 hours 20 minutes ago Form 8.3 - The Vanguard Group, Inc.: Greencore Group plc
Published on 12/22/2025 at 18:05, 2 days 1 hour ago Covivio - Treasury shares transactions between December 15th , 2025 and December 19th, 2025
Published on 12/22/2025 at 17:35, 2 days 1 hour ago DISCLOSURE OF TRANSACTIONS IN OWN SHARES FROM DECEMBER 15 TO DECEMBER 19, 2025
Published on 12/22/2025 at 15:00, 2 days 4 hours ago Capital increase through exercise of subscription rights
Published on 12/22/2025 at 09:18, 2 days 10 hours ago GUILLEMOT CORPORATION: Information regarding the total number of voting rights and shares 11/12/2025